BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 27165126)

  • 1. Novel patient-derived xenograft mouse model for pancreatic acinar cell carcinoma demonstrates single agent activity of oxaliplatin.
    Hall JC; Marlow LA; Mathias AC; Dawson LK; Durham WF; Meshaw KA; Mullin RJ; Synnott AJ; Small DL; Krishna M; von Hoff D; Schüler J; Hart SN; Couch FJ; Colon-Otero G; Copland JA
    J Transl Med; 2016 May; 14(1):129. PubMed ID: 27165126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Response of germline BRCA2-mutated advanced pancreatic acinar cell carcinoma to olaparib: A case report.
    Li M; Mou Y; Hou S; Cao D; Li A
    Medicine (Baltimore); 2018 Nov; 97(45):e13113. PubMed ID: 30407325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metastatic Acinar Cell Carcinoma of the Pancreas: A Retrospective Cohort Study on Systemic Chemotherapy and Review of the Literature.
    Busch E; Werft W; Bougatf N; Hackert T; Jäger D; Springfeld C; Berger AK
    Pancreas; 2021 Mar; 50(3):300-305. PubMed ID: 33835959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline BRCA2 variants in advanced pancreatic acinar cell carcinoma: A case report and review of literature.
    Lee CL; Holter S; Borgida A; Dodd A; Ramotar S; Grant R; Wasson K; Elimova E; Jang RW; Moore M; Kim TK; Khalili K; Moulton CA; Gallinger S; O'Kane GM; Knox JJ
    World J Gastroenterol; 2022 Dec; 28(45):6421-6432. PubMed ID: 36533108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exceptional Response of Pancreatic Acinar Cell Carcinoma and Bile Duct Cancer to Platinum-Based Chemotherapy in a Family With a Germline BRCA2 Variant.
    Sunami T; Yamada A; Kondo T; Kanai M; Nagai K; Uchida Y; Yokode M; Matsumori T; Uza N; Murakami H; Yamada T; Muto M
    Pancreas; 2022 Oct; 51(9):1258-1262. PubMed ID: 37078954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen.
    Yoo C; Kim BJ; Kim KP; Lee JL; Kim TW; Ryoo BY; Chang HM
    Cancer Res Treat; 2017 Jul; 49(3):759-765. PubMed ID: 27857025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC.
    Florou V; Elliott A; Bailey MH; Stone D; Affolter K; Soares HP; Nevala-Plagemann C; Scaife C; Walker P; Korn WM; Lou E; Shroff RT; Hosein PJ; Garrido-Laguna I
    Clin Cancer Res; 2023 Sep; 29(17):3408-3417. PubMed ID: 37266563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic acinar cell carcinoma with bilateral ovarian metastases, panniculitis and polyarthritis treated with FOLFIRINOX chemotherapy regimen. A case report and review of the literature.
    Callata-Carhuapoma HR; Pato Cour E; Garcia-Paredes B; Fernandez RM; Mendoza Fernandez ML; Fernandez AM; De La Rosa CA; Sotelo Lezama MJ; Cabezas-Camarero S; Sastre Varela J
    Pancreatology; 2015; 15(4):440-4. PubMed ID: 25959244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole exome sequencing reveals recurrent mutations in BRCA2 and FAT genes in acinar cell carcinomas of the pancreas.
    Furukawa T; Sakamoto H; Takeuchi S; Ameri M; Kuboki Y; Yamamoto T; Hatori T; Yamamoto M; Sugiyama M; Ohike N; Yamaguchi H; Shimizu M; Shibata N; Shimizu K; Shiratori K
    Sci Rep; 2015 Mar; 5():8829. PubMed ID: 25743105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of chemotherapy combined with toripalimab in PD-L1-positive and high tumor mutation burden pancreatic acinar cell carcinoma: case report.
    Xu H; Wang X; Zhou S; Hu Q; Cao D
    Tumori; 2021 Dec; 107(6):NP24-NP27. PubMed ID: 33345750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic acinar cell carcinoma: A review on molecular profiling of patient tumors.
    Al-Hader A; Al-Rohil RN; Han H; Von Hoff D
    World J Gastroenterol; 2017 Dec; 23(45):7945-7951. PubMed ID: 29259370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acinar cell carcinoma of the pancreas: a rare disease with different diagnostic and therapeutic implications than ductal adenocarcinoma.
    Kruger S; Haas M; Burger PJ; Ormanns S; Modest DP; Westphalen CB; Kleespies A; Angele MK; Hartwig W; Bruns CJ; Kirchner T; Werner J; Heinemann V; Boeck S
    J Cancer Res Clin Oncol; 2016 Dec; 142(12):2585-2591. PubMed ID: 27629876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged survival in a patient with BRCA2 associated metastatic pancreatic cancer after exposure to camptothecin: a case report and review of literature.
    James E; Waldron-Lynch MG; Saif MW
    Anticancer Drugs; 2009 Aug; 20(7):634-8. PubMed ID: 19433978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor growth inhibition by olaparib in BRCA2 germline-mutated patient-derived ovarian cancer tissue xenografts.
    Kortmann U; McAlpine JN; Xue H; Guan J; Ha G; Tully S; Shafait S; Lau A; Cranston AN; O'Connor MJ; Huntsman DG; Wang Y; Gilks CB
    Clin Cancer Res; 2011 Feb; 17(4):783-91. PubMed ID: 21097693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surgical resection of hepatic and rectal metastases of pancreatic acinar cell carcinoma (PACC): a case report.
    Ohara Y; Oda T; Enomoto T; Hisakura K; Akashi Y; Ogawa K; Owada Y; Domoto Y; Miyazaki Y; Shimomura O; Kurata M; Ohkohchi N
    World J Surg Oncol; 2018 Aug; 16(1):158. PubMed ID: 30075727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and treatment analysis of pancreatic acinar cell carcinoma: A single institutional comparison to pancreatic ductal adenocarcinoma.
    Huang X; Li M; Zhang L; Xiong J; Lu H; Tian B
    Surg Oncol; 2021 Jun; 37():101528. PubMed ID: 33611029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new herbal formula BP10A exerted an antitumor effect and enhanced anticancer effect of irinotecan and oxaliplatin in the colon cancer PDTX model.
    Kim J; Kim HY; Hong S; Shin S; Kim YA; Kim NS; Bang OS
    Biomed Pharmacother; 2019 Aug; 116():108987. PubMed ID: 31112870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOLFIRINOX as first-line treatment for unresectable acinar cell carcinoma of the pancreas: a case report.
    Schempf U; Sipos B; König C; Malek NP; Bitzer M; Plentz RR
    Z Gastroenterol; 2014 Feb; 52(2):200-3. PubMed ID: 24526405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the NTRK Fusion Gene in Pancreatic Acinar Cell Carcinoma: A Case Report and Review of the Literature.
    Gupta M; Sherrow C; Krone ME; Blais EM; Pishvaian MJ; Petricoin EF; Matrisian LM; DeArbeloa P; Gregory G; Brown A; Zalewski O; Prinzing G; Roche C; Kanehira K; Mukherjee S; Iyer R; Fountzilas C
    J Natl Compr Canc Netw; 2021 Jan; 19(1):10-15. PubMed ID: 33406492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer Xenografts.
    Nukatsuka M; Nakagawa F; Takechi T
    Anticancer Res; 2015 Sep; 35(9):4605-15. PubMed ID: 26254349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.